A Randomized, Multi-regional, Double-blind, Parallel-group, Placebo-controlled Phase 3 Study to Assess the Safety and Efficacy of 6 Months Treatment with Tigulixostat in Gout Patients with Hyperuricemia
- Promotore
- LG Chem
- Acronimo
- LG-GDCL010
- Struttura
- Reumatologia
- Sperimentatore principale
- Stobbione Paolo
- Stato arruolamento
- In attesa di arruolamento